124 related articles for article (PubMed ID: 36374960)
21. M2 macrophages regulate KDM6B/PFKFB2 metabolic reprogramming of cervical squamous cell carcinoma through CXCL1.
Yu J; Huang L; Cao L
Cell Mol Biol (Noisy-le-grand); 2024 Jun; 70(6):78-84. PubMed ID: 38836678
[TBL] [Abstract][Full Text] [Related]
22. Uncovering of potential molecular markers for cervical squamous cell carcinoma (CESC) based on analysis of methylated-differentially expressed genes.
Liu M; Wei D; Nie Q; Peng L; He L; Cui Y; Ye Y
Taiwan J Obstet Gynecol; 2022 Jul; 61(4):663-671. PubMed ID: 35779918
[TBL] [Abstract][Full Text] [Related]
23. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
24. Development and assessment of an RNA editing-based risk model for the prognosis of cervical cancer patients.
Zhu Z; Lu J
Medicine (Baltimore); 2024 May; 103(19):e38116. PubMed ID: 38728474
[TBL] [Abstract][Full Text] [Related]
25. Construction of prognosis model of pyroptosis gene and characterization of tumor microenvironment infiltration in cervical cancer.
Zhang M; Wu P
Medicine (Baltimore); 2022 Nov; 101(46):e31599. PubMed ID: 36401372
[TBL] [Abstract][Full Text] [Related]
26. Identification of cervical squamous cell carcinoma feature genes and construction of a prognostic model based on immune-related features.
He C; Ren L; Yuan M; Liu M; Liu K; Qian X; Lu J
BMC Womens Health; 2022 Sep; 22(1):365. PubMed ID: 36057587
[TBL] [Abstract][Full Text] [Related]
27. The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer.
Guo Y; Bai Y; Wang L; Xu Z; Wang X; Wang W
Medicine (Baltimore); 2022 Jul; 101(26):e29818. PubMed ID: 35777046
[TBL] [Abstract][Full Text] [Related]
28. ERBB3 methylation and immune infiltration in tumor microenvironment of cervical cancer.
Yang X; Chen Y; Li M; Zhu W
Sci Rep; 2022 May; 12(1):8112. PubMed ID: 35581263
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of S1PR2 is correlated with poor prognosis and immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma.
Zhang Y; Wang H; Lu J; Lv Q; Yun B; Ge Z; Yan L
Int J Immunopathol Pharmacol; 2023; 37():3946320231178131. PubMed ID: 37232164
[No Abstract] [Full Text] [Related]
30. Identification of Oxidative Stress-Associated Molecular Subtypes and Signature for Predicting Survival Outcome of Cervical Squamous Cell Carcinoma.
Wang L; Qu H; Ma X; Liu X
Oxid Med Cell Longev; 2022; 2022():1056825. PubMed ID: 36225179
[TBL] [Abstract][Full Text] [Related]
31. Characterization of tumor microenvironment and tumor immunology based on the double-stranded RNA-binding protein related genes in cervical cancer.
Li J; Wan C; Li X; Quan C; Li X; Wu X
J Transl Med; 2023 Sep; 21(1):647. PubMed ID: 37735483
[TBL] [Abstract][Full Text] [Related]
32. RNA modification "writer"-mediated RNA modification patterns and tumor microenvironment characteristics of cervical cancer.
Qu Y; Zhu H; Kong C; Zheng X; Wang D; Chen X; Yuan D
Clin Transl Oncol; 2022 Jul; 24(7):1413-1424. PubMed ID: 35220552
[TBL] [Abstract][Full Text] [Related]
33. Prognosis, immune microenvironment, and personalized treatment prediction in Rho GTPase-activating protein 4-mutant cervical cancer: Computer strategies for precision oncology.
Lu X; Ying Y; Zhang W; Zhang J; Li R; Wang W
Life Sci; 2023 Feb; 315():121360. PubMed ID: 36608869
[TBL] [Abstract][Full Text] [Related]
34. Construction and validation of prognostic prediction established on N6-methyladenosine related genes in cervical squamous cell carcinoma.
Chen D; Guo W; Yu H; Yang J
Transl Cancer Res; 2022 Sep; 11(9):3064-3079. PubMed ID: 36237271
[TBL] [Abstract][Full Text] [Related]
35. Necroptosis-related lncRNA signature predicts prognosis and immune response for cervical squamous cell carcinoma and endocervical adenocarcinomas.
Lin Z; Zou J; Sui X; Yao S; Lin L; Wang J; Zhao J
Sci Rep; 2022 Sep; 12(1):16285. PubMed ID: 36175606
[TBL] [Abstract][Full Text] [Related]
36. ALKBH5 inhibits the SIRT3/ACC1 axis to regulate fatty acid metabolism via an m6A-IGF2BP1-dependent manner in cervical squamous cell carcinoma.
Zhen L; Pan W
Clin Exp Pharmacol Physiol; 2023 May; 50(5):380-392. PubMed ID: 36705046
[TBL] [Abstract][Full Text] [Related]
37. Novel Prognostic Biomarkers for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients via Analysis of Competing Endogenous RNA (ceRNA) Network.
Dong Y; Wen W; Yuan T; Liu L; Li X
Dis Markers; 2023; 2023():1766080. PubMed ID: 36817087
[TBL] [Abstract][Full Text] [Related]
38. Identification of Key Genes in Association with Progression and Prognosis in Cervical Squamous Cell Carcinoma.
Meng H; Liu J; Qiu J; Nie S; Jiang Y; Wan Y; Cheng W
DNA Cell Biol; 2020 May; 39(5):848-863. PubMed ID: 32202912
[TBL] [Abstract][Full Text] [Related]
39. Identification of
Zhao S; Yu M
DNA Cell Biol; 2020 Feb; 39(2):255-272. PubMed ID: 31977248
[TBL] [Abstract][Full Text] [Related]
40. Prognostic genes in the tumor microenvironment in cervical squamous cell carcinoma.
Pan XB; Lu Y; Huang JL; Long Y; Yao DS
Aging (Albany NY); 2019 Nov; 11(22):10154-10166. PubMed ID: 31740624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]